|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental |
| discovery after long-term oral contraceptive use. |
| Korula J; Yellin A; Kanel G; Campofiori G; Nichols P |
| WESTERN JOURNAL OF MEDICINE. 1991 Oct;155(4):416-8. |
| In March 1989, ultrasonography revealed a hepatic mass in a 40 year old nulliparous woman who was then referred to |
| the University of Southern California--Los Angeles (UCLA) Liver Unit. She exhibited no symptoms of a liver |
| condition. From 19-28 years old, she took the combined oral contraceptive (OC) Ovulen 21 for irregular menses. After |
| a brief period of taking Ortho Novum 1/80, she took Demulen 1/35-24 between ages 28-34. Her physician diagnoses |
| endometriosis at 34. He stopped OC therapy and prescribed the progestin Norlutate. She had no history of hepatitis, |
| toxin exposure, and previous liver disease. Further no one in her family had had liver disease or neoplasms. |
| Computer tomography identified a 6.5 cm x 3.5 cm mass in the right lobe of the liver which matched a cold defect on |
| a liver scan using technetium Tc 99m sulfur colloid. The mass selectively took up gallium. Arteriography revealed |
| the mass to be a vascular tumor, but it did not exhibit a typical vascular pattern of an adenoma or the neovascularity |
| of hepatocellular carcinoma. Physicians at UCLA used peritoneoscopy to take percutaneous needle biopsies of the |
| right lobe which confirmed a hepatic adenoma. they then removed the right lobe of the liver. The remaining part of |
| the liver was normal. Histologic examinations of the removed section showed features of a well differentiated |
| hepatocellular carcinoma. Further tumor cells had invaded normal hepatic parenchyma. The physicians believed |
| that hepatic adenoma was in the process of transforming into hepatocellular carcinoma in this patient. They thought |
| that long term OC use, and possibly long term progestin use, may have contributed to the formation of the liver |
| neoplasms. They emphasized the need for a pilot study to develop guidelines on surveillance ultrasonography of |
| women taking OCs over a long period. (PubHealth.info Document ID: CONT3T 2042-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Hepatocellular carcinoma coexisting with hepatic |
| adenoma. Incidental discovery after long-term oral contraceptive use.", is(are) Korula J; Yellin A; Kanel G; |
| Campofiori G; Nichols P. The source of this article is "WESTERN JOURNAL OF MEDICINE. 1991 Oct;155(4):416- |
| 8.". This article was published in 1991 in English language(s). (PubHealth.info® Document ID: CONT3T 2042-06. All |
| rights reserved with PubHealth.info) PIN: 12042 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |